Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01470001 · ClinicalTrials.gov registry record · NA
The Effect of Solifenacin on Post Void Dribbling in Women
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT01470001 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 118 participants.
The verdict
NCT01470001, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.
Interventions
- DRUG solifenacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01470001
The ClinicalTrials.gov registry entry for NCT01470001 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which solifenacin is the first listed.
NCT01470001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01470001 about?
NCT01470001 is a clinical study titled "The Effect of Solifenacin on Post Void Dribbling in Women". This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.
What is the current status of trial NCT01470001?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2011-11. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01470001?
The interventions under investigation include: solifenacin (DRUG).
Who is sponsoring clinical trial NCT01470001?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.